论文部分内容阅读
子宫内膜癌是女性生殖系统中最常见的恶性肿瘤之一,其发病率呈逐年上升和年轻化趋势。随着子宫内膜癌发病率增高,对其开展筛查日益受到关注。子宫内膜癌的筛查,属于对高危人群进行的选择性筛查,但至今尚未建立成熟的筛查方法。目前对子宫内膜癌有无创性筛查,包括血清学CA125检测,以及经阴道超声检查;有创性筛查主要是诊断性刮宫和宫腔镜下取活体组织病理学检查。子宫内膜细胞学检查不能替代病理组织标本的检查效果,并且缺乏细胞学诊断标准,至今在推广使用中有一定难度。子宫内膜微量组织病理学检查因操作简便,微创,且可以根据病理结果做出较明确的诊断而备受关注,但在临床推广使用,尚需积累临床数据。
Endometrial cancer is one of the most common malignant tumors in the female reproductive system, and its incidence is increasing year by year and younger. With the increase of the incidence of endometrial cancer, screening for it is receiving more and more attention. Screening for endometrial cancer is a selective screening of high-risk groups, but so far no established screening method has been established. Currently there are non-invasive screening of endometrial cancer, including serological CA125 test, and transvaginal ultrasound; invasive screening is mainly diagnostic curettage and hysteroscopic removal of living tissue pathology. Endometrial cytology can not replace the examination of pathological tissue specimens, and the lack of cytological diagnostic criteria, so far in the promotion of a certain degree of difficulty. Endometrial micro-histopathological examination due to simple, minimally invasive, and can make a more clear diagnosis based on pathological findings and much attention, but in clinical use, still need to accumulate clinical data.